查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1528111

有源植入式醫療設備的全球市場

Active Implantable Medical Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球有源植入醫療設備市場將達到 513 億美元

有源植入式醫療設備的全球市場預計 2023 年為 305 億美元，預計到 2030 年將達到 513 億美元，2023 年至 2030 年複合年成長率為 7.7%。植入式心臟整流去顫器是本報告分析的細分市場之一，預計複合年成長率為 7.9%，到分析期結束時將達到 172 億美元。在分析期間，植入式心臟心律調節器市場的複合年成長率預計為 8.6%。

美國市場預估成長84億美元，中國複合年增率為7.3%

2023年美國主動植入式醫療設備市場規模預估為84億美元。中國作為世界第二大經濟體，預計2030年市場規模將達79億美元，2023-2030年分析期間複合年成長率為7.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 7.2% 和 6.2%。在歐洲，德國的複合年成長率預計約為 6.2%。

全球主動植入式醫療設備市場 - 主要趨勢與促進因素總結

為什麼有源植入式醫療設備會徹底改變醫療保健？

主動式植入式醫療設備(AIMD) 已成為醫療保健產業的遊戲規則改變者，為管理慢性病和改善病患治療效果提供了前所未有的解決方案。這些設備包括心律調節器、心臟去顫器、神經刺激設備和人工電子耳，旨在植入體內監測、診斷和治療各種醫療狀況。 AIMD 中先進技術的整合顯著增強了其功能，可實現持續監控並向醫療保健提供者即時傳輸資料。這種能力不僅可以及時進行醫療干預，還可以減少再入院和醫療費用。 AIMD 的發展代表了個人化醫療的重大飛躍，可根據每位患者的特定需求提供量身定做的治療方法。

技術進步將如何提高 AIMD 的有效性？

技術進步對 AIMD 的發展和有效性發揮著至關重要的作用。隨著微電子、無線通訊和節能電源的引入，AIMD 變得更小、更可靠、更耐用。生物相容性材料的創新提高了植入的安全性和耐用性，降低了副作用和設備故障的風險。此外，人工智慧和機器學習演算法的整合使 AIMD 能夠適應患者生理狀態的變化並最佳化治療結果。這些技術進步不僅提高了AIMD的性能，還擴大了其應用範圍，使其能夠解決更廣泛的疾病狀態。因此，患者可以受益於更有效、侵入性更小的治療方法，從而提高生活品質並延長存活率。

哪些趨勢和市場動態會影響 AIMD？

AIMD 市場受到多種新興趨勢和市場動態的影響。世界人口老化是推動 AIMD 需求的關鍵因素，因為心血管疾病、神經系統疾病和聽力損失等慢性疾病的盛行率隨著老齡化的成長而增加。此外，糖尿病和肥胖症等與文明病的增加進一步增加了對先進醫療干預措施的需求。法律規範和核准流程也變得更加嚴格，以確保 AIMD 的安全性和有效性。此外，遠端醫療和遠端監控技術的進步補充了 AIMD 的能力，並實現患者和醫療保健提供者之間的無縫連接。這些趨勢支撐了 AIMD 在應對現代社會複雜的醫療保健挑戰方面日益成長的重要性。

有源植入醫療設備市場成長的驅動力是什麼？

有源植入式醫療設備市場的成長受到多種因素的推動。關鍵因素之一是持續的技術創新，提高目前植入式醫療設備的功能和可靠性。慢性病的增加和人口老化對 AIMD 產生了巨大的需求。此外，醫療保健基礎設施的擴張，尤其是在新興市場，為 AIMD 製造商帶來了巨大的成長機會。在醫療設備製造商成功的臨床結果和廣泛的行銷努力的推動下，患者對 AIMD 的認知和接受度也在不斷提高。監管支持和有利的報銷政策正在進一步加速市場採用。此外，微創手術的趨勢以及 AIMD 與遠端監控和管理數位健康平台的整合正在推動市場向前發展。總的來說，這些因素促進了主動植入醫療設備市場的強勁成長和動態發展，使其成為現代醫療保健服務的重要組成部分。

調查企業舉例（共13家）

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • MED-EL Elektromedizinische Gerate Gesellschaft mbH
  • Medtronic PLC
  • Nurotron Biotechnology Co., Ltd.
  • Sonova AG
  • William Demant Holding A/S

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 比賽

簡介目錄
Product Code: MCP10058

Global Active Implantable Medical Devices Market to Reach US$51.3 Billion by 2030

The global market for Active Implantable Medical Devices estimated at US$30.5 Billion in the year 2023, is expected to reach US$51.3 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$17.2 Billion by the end of the analysis period. Growth in the Implantable Cardiac Pacemakers segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.4 Billion While China is Forecast to Grow at 7.3% CAGR

The Active Implantable Medical Devices market in the U.S. is estimated at US$8.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$7.9 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Active Implantable Medical Devices Market - Key Trends and Drivers Summarized

Why Are Active Implantable Medical Devices Revolutionizing Healthcare?

Active implantable medical devices (AIMDs) have emerged as a game-changer in the healthcare industry, offering unprecedented solutions for managing chronic diseases and improving patient outcomes. These devices, which include pacemakers, defibrillators, neurostimulators, and cochlear implants, are designed to be implanted into the body to monitor, diagnose, and treat various medical conditions. The integration of advanced technologies in AIMDs has significantly enhanced their functionality, enabling continuous monitoring and real-time data transmission to healthcare providers. This capability not only allows for timely medical interventions but also reduces hospital readmissions and healthcare costs. The evolution of AIMDs represents a significant leap forward in personalized medicine, providing tailored treatments that cater to the specific needs of individual patients.

How Do Technological Advancements Boost AIMDs' Effectiveness?

Technological advancements have played a pivotal role in the development and effectiveness of AIMDs. The incorporation of microelectronics, wireless communication, and energy-efficient power sources has made these devices smaller, more reliable, and longer-lasting. Innovations in biocompatible materials have improved the safety and durability of implants, reducing the risk of adverse reactions and device failure. Moreover, the integration of artificial intelligence and machine learning algorithms enables AIMDs to adapt to the changing physiological conditions of patients, optimizing therapeutic outcomes. These technological strides not only enhance the performance of AIMDs but also expand their applications, making them suitable for a wider range of medical conditions. As a result, patients benefit from more effective and less invasive treatment options, leading to better quality of life and prolonged survival rates.

What Trends and Market Dynamics Are Influencing AIMDs?

The AIMD market is influenced by several emerging trends and market dynamics. The aging global population is a significant factor driving the demand for AIMDs, as the prevalence of chronic diseases such as cardiovascular disorders, neurological conditions, and hearing impairments increases with age. Additionally, the rise in lifestyle-related diseases, such as diabetes and obesity, has further escalated the need for advanced medical interventions. Regulatory frameworks and approval processes are becoming more stringent, ensuring the safety and efficacy of AIMDs, which in turn boosts patient confidence and adoption rates. Furthermore, advancements in telemedicine and remote monitoring technologies are complementing the functionality of AIMDs, enabling seamless connectivity between patients and healthcare providers. These trends underscore the growing importance of AIMDs in addressing the complex healthcare challenges of the modern world.

What Drives the Growth in the Active Implantable Medical Devices Market?

The growth in the active implantable medical devices market is driven by several factors. One of the primary drivers is the continuous technological innovation that enhances the capabilities and reliability of these devices. The increasing prevalence of chronic diseases and the growing aging population create a substantial demand for AIMDs. Moreover, the expanding healthcare infrastructure, particularly in emerging markets, provides significant growth opportunities for AIMD manufacturers. Patient awareness and acceptance of these devices are also on the rise, driven by successful clinical outcomes and extensive marketing efforts by medical device companies. Regulatory support and favorable reimbursement policies further accelerate market adoption. Additionally, the trend towards minimally invasive surgical procedures and the integration of AIMDs with digital health platforms for remote monitoring and management propel the market forward. These factors collectively contribute to the robust growth and dynamic evolution of the active implantable medical devices market, making it a critical component of modern healthcare delivery.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • MED-EL Elektromedizinische Gerate Gesellschaft m.b.H.
  • Medtronic PLC
  • Nurotron Biotechnology Co., Ltd.
  • Sonova AG
  • William Demant Holding A/S

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Active Implantable Medical Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Spurs Demand for AIMDs
    • Aging Population Expands Addressable Market Opportunity for AIMDs
    • Technological Innovations Propel Growth in Active Implantable Medical Devices
    • Advances in Microelectronics Strengthen Business Case for AIMDs
    • Integration of AI and Machine Learning Accelerates Demand for Intelligent Implants
    • Enhanced Biocompatible Materials Drive Adoption of Safer AIMDs
    • Telemedicine and Remote Monitoring Technologies Propel Market Growth
    • Minimally Invasive Procedures Sustain Growth in AIMD Adoption
    • Expanding Healthcare Infrastructure in Emerging Markets Expands Market Opportunities
    • Innovations in Power Sources and Energy Efficiency Propel AIMD Advancements
    • Digital Health Integration Drives Demand for Connected AIMDs
    • Data Security and Privacy Concerns Create Challenges and Opportunities for AIMDs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Active Implantable Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Active Implantable Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Implantable Cardioverter Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Implantable Cardioverter Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Implantable Cardiac Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Implantable Cardiac Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Implantable Cardiac Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ventricular Assist Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ventricular Assist Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Ventricular Assist Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Implantable Hearing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Implantable Hearing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Implantable Hearing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Active Implantable Medical Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Neurostimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Neurostimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Neurostimulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • JAPAN
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • CHINA
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: China 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • EUROPE
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Active Implantable Medical Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Active Implantable Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Europe 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • FRANCE
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 41: France Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: France Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: France 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • GERMANY
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Germany Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Germany 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 47: Italy Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Italy Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Italy 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: UK Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: UK 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 59: Rest of World Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Rest of World Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Rest of World 16-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2014, 2024 & 2030

IV. COMPETITION